Area of research
Hematology · Geriatrics and Gerontology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Frailty in Older Adults, Cancer survivorship and care, and Hematopoietic Stem Cell Transplantation.
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia
A real‐world data analysis of predictors of early mortality after a diagnosis of multiple myeloma
Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Simplified frailty assessment tools: are we really capturing frailty or something else?
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies
Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant
Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia
Survivorship care for older adults with cancer: U13 conference report
Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)